Non-invasive Coronary Imaging Market Size & Forecast Report - 2026 to 2030

The global non-invasive coronary imaging market size is projected to grow at a significant CAGR of around 7% during the forecast period from 2022 to 2028. The rising prevalence of cardiovascular disease around the world is a primary factor driving the market growth. According to WHO (World Health Organization), it is estimated that 17.9 million people died from cardiovascular disease in 2019. Furthermore, the latest information shared by CDC (Centers for Disease Control and Prevention), approximately 697,000 people died in the United States from heart disease in 2020. Coronary heart disease is the most common type of heart disease, causing 382,820 deaths in 2020 in the United States.

Market Drivers:

Increasing Prevalence of Cardiovascular Diseases: Cardiovascular diseases, including coronary artery disease, remain a leading cause of morbidity and mortality worldwide. The rising prevalence of these diseases is driving the demand for non-invasive coronary imaging techniques as they provide valuable diagnostic information without the need for invasive procedures.

Advancements in Imaging Technologies: Technological advancements have significantly improved non-invasive coronary imaging techniques, enhancing their accuracy, resolution, and diagnostic capabilities. Techniques such as computed tomography angiography (CTA), magnetic resonance angiography (MRA), and intravascular ultrasound (IVUS) have undergone significant advancements, making them more accessible, cost-effective, and reliable.

Minimally Invasive and Risk Reduction: Non-invasive coronary imaging techniques offer a safer alternative to invasive procedures, such as cardiac catheterization. They eliminate the need for catheters to be inserted into the coronary arteries, reducing the associated risks and complications. Patients and healthcare providers are increasingly opting for non-invasive imaging techniques to minimize patient discomfort, reduce procedural risks, and improve patient outcomes.

Growing Aging Population: The global population is aging, leading to an increased prevalence of cardiovascular diseases. As the elderly population grows, the demand for non-invasive coronary imaging techniques is expected to rise. Non-invasive imaging methods are particularly beneficial for older adults who may be at higher risk for complications associated with invasive procedures.

Rising Focus on Preventive Healthcare: There is a growing emphasis on preventive healthcare and early disease detection. Non-invasive coronary imaging techniques enable the identification of early signs of coronary artery disease, allowing for timely intervention and prevention. This preventive approach is gaining traction, driving the demand for non-invasive imaging technologies.

Cost-effectiveness and Time Efficiency: Non-invasive coronary imaging techniques offer cost-effective and time-efficient diagnostic solutions. They eliminate the need for hospitalization and invasive procedures, reducing healthcare costs and patient waiting times. Non-invasive imaging techniques can provide rapid and accurate diagnostic results, facilitating timely decision-making and treatment planning.

Increasing Awareness and Adoption: Awareness among both healthcare professionals and patients regarding the benefits of non-invasive coronary imaging is growing. Physicians are increasingly recommending non-invasive imaging techniques as a first-line diagnostic tool for coronary artery disease. Patients are also becoming more aware and proactive about their health, leading to increased demand for non-invasive imaging procedures.

Market Snapshot:

Market Insights:

By modality, the cardiac computed tomography segment is expected to hold the largest market share by 2028

The global non-invasive coronary imaging market is bifurcated into modality, end-use, and geography. On the basis of modality, the market is further segmented into radionuclide cardiac imaging, echocardiography, cardiac computed tomography, and cardiac magnetic resonance imaging. The cardiac computed tomography segment is accounted to hold the largest revenue share of around 1/3 market share in 2021. On the flip side, the radionuclide cardiac imaging segment is accounted to register the fastest growth rate over the forecast period. The increasing adoption of the technology due to its various benefits such as image clarity, accurate disease detection, shorter image capture time, and others are expected to fuel the segment growth over the forecast period.

By end-use, the research institute segment dominated the global market in 2021

On the basis of end-use, the market is segmented into hospitals, diagnostic imaging centers, and research institutes. The research institute segment dominated the global non-invasive coronary imaging market in 2021 and is expected to maintain its dominance over the forecast period. The rising demand for the development of more accurate and efficient techniques to diagnose various types of disorders such as ischemia, myocardia, and other types of cardiac disorders is a major factor to drive the segment growth. Furthermore, the increasing investment in research and development by pharmaceuticals and biotechnology companies is further anticipated to uplift the segment growth over the forecast period.

To know more about the research study, request sample papers

The non-invasive coronary imaging comprehensive study analyzes industry trends, market size, competitive analysis, and market forecast – 2022 to 2028. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The non-invasive coronary imaging market research report presents the analysis of each segment from 2019 to 2028 considering 2021 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2022 to 2028.

Historical & Forecast Period

• 2019-20 – Historical Year
• 2021 – Base Year
• 2022-2028 – Forecast Period

Market Segmentation:

By Modality:

• Radionuclide Cardiac Imaging
• Echocardiography
• Cardiac Computed Tomography
• Cardiac Magnetic Resonance Imaging

By End-Use:

• Hospitals
• Diagnostic Imaging Centers
• Research Institute

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis:

By region, North America is expected to hold the largest revenue share by the end of the analysis period

On the basis of region, North America dominated the global non-invasive coronary imaging market in 2021 and anticipated to maintain its dominance over the forecast period. The technological advancement in healthcare and the well-established healthcare infrastructure are some major factors driving the market growth in the region. Furthermore, the rising prevalence of chronic diseases, the growing rate of obesity, and the significant growth in research & development activities are further anticipated to propel the market growth in North America. On the flip side, the Asia Pacific is accounted to grow at the highest CAGR over the forecast period.

Geographically, the non-invasive coronary imaging market report comprises dedicated sections centering on the regional market revenue and trends. The non-invasive coronary imaging market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The non-invasive coronary imaging market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Non-invasive coronary imaging market estimates have also been provided for the historical years 2019 & 2020 along with forecasts for the period from 2022 – 2028.

Competitive Assessment:

Some of the major market players operating in the global non-invasive coronary imaging market are Toshiba Medical Systems, Hologic, Inc., Carestream Health, Inc., and GE Healthcare. Companies are exploring markets through expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Toshiba Medical Systems
• Hologic, Inc.
• Carestream Health, Inc.
• GE Healthcare
• Siemens Healthcare
• Philips Healthcare
• Hitachi Medical Corporation
• Others

Key Questions Answered by Non-invasive Coronary Imaging Market Report

• Global non-invasive coronary imaging market forecasts from 2022-2028
• Regional market forecasts from 2022-2028 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2022-2028 covering 15 major countries from the regions as mentioned above
• Non-invasive coronary imaging submarket forecasts from 2022-2028 covering the market by modality, end-use, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level non-invasive coronary imaging markets from 2022-2028
• Competitive Landscape and market positioning of the top 10 players operating in the market